Related Experiment Videos
Diabetes-induced variation in hepatic binding protein.
Biochemical and Biophysical Research Communications
|August 30, 1983
Summary
Hepatocyte asialoorosomucoid binding capacity significantly decreases in streptozotocin-induced diabetes. Receptor levels drop notably by 11 days, impacting liver cell function in diabetic rats.
Area of Science:
- Biochemistry
- Cell Biology
- Endocrinology
Background:
- Asialoorosomucoid binding by hepatocytes is a key indicator of liver function.
- Diabetes mellitus, induced by streptozotocin, causes significant metabolic disturbances.
Purpose of the Study:
- To investigate the impact of streptozotocin-induced diabetes on the binding capacity of hepatocytes for asialoorosomucoid.
- To quantify changes in hepatocyte receptor concentration over time in a diabetic rat model.
Main Methods:
- Measurement of asialoorosomucoid binding capacity in hepatocytes from normal and diabetic rats.
- Utilizing streptozotocin injection to induce diabetes in Sprague-Dawley rats.
- Assessing receptor concentration at 4 and 11 days post-injection.
Main Results:
- A slight decrease in total receptor concentration was observed 4 days after streptozotocin injection.
- A more marked reduction in cell surface receptor occurred at 4 days.
- By 11 days post-injection, hepatocyte asialoorosomucoid binding capacity was reduced to approximately 70% of normal levels.
Conclusions:
- Streptozotocin-induced diabetes leads to a progressive decline in hepatocyte asialoorosomucoid binding capacity.
- The reduction in binding capacity is associated with decreased total and cell surface receptor concentrations.
- These findings highlight the detrimental effects of diabetes on specific liver cell functions.